Traditional Chinese medicine as an add-on treatment for mycobacterium abscessus in the lungs
Part of Infections, Lungs & breathing clinical trials.
This study tests if adding traditional Chinese medicine to standard treatment helps people with a lung infection called Mycobacterium abscessus. It may improve recovery and reduce side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a lung infection caused by Mycobacterium abscessus bacteria.
- You have already finished the first part of the standard treatment your doctor recommended.
- Your blood, heart, liver, kidneys, and other organs are working well enough based on tests done within the week before starting.
- You are not allergic to the study medicine.
- You do not have other active lung infections like tuberculosis or more than one type of nontuberculous mycobacteria.
- You are not pregnant or breastfeeding and agree to avoid other investigational drugs during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new combination of antibiotics (Arm D) against the standard treatment for people with a difficult-to-treat lung infection called Mycobacterium abscessus. It is for adults and teens aged 12 and older, including those with cystic fibrosis.
This study tests whether a new antibiotic, Contezolid, can quickly reduce the amount of Mycobacterium abscessus in your lungs. It may be a treatment option if you have had a positive sputum test in the past 6 months.
This study tests if a drug called sitafloxacin can quickly kill mycobacterium abscessus bacteria in the lungs. It may help people with this hard-to-treat infection find a more effective treatment.
This trial tests if adding a Chinese herbal formula (BaiDiZiYin ShenQiYiFei) to standard tuberculosis drugs helps improve symptoms like shortness of breath, fatigue, and coughing. It may be helpful for people diagnosed with pulmonary TB who also have signs of Qi and Yin deficiency (a traditional Chinese medicine pattern).
This trial tests whether omadacycline (an antibiotic) can safely and effectively treat a rare lung infection caused by Mycobacterium abscessus bacteria. If you have this infection, this study may help doctors understand if this antibiotic works better than current treatments.
This trial tests whether the drug Contezolid can quickly kill the bacteria that cause MAC lung disease, a type of lung infection. It is for people who have not been treated for this infection in the last 3 months.
Hear when a new Mycobacterium Abscessus Pulmonary Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.